Crystal structure of the SARS-CoV-2 (COVID-19) main protease in complex with inhibitor UAWJ9-36-3

Zilei Xia (Contributor)
Michael Dominic Sacco (Contributor)
Yanmei Hu (Contributor)
Chunlong Ma (Contributor)
Xiangzhi Meng (Contributor)
Fushun Zhang (Contributor)
Tommy Szeto (Contributor)
Yan Xiang (Contributor)
Yu Chen (Contributor)
Jun Wang (Contributor)

Dataset

Date made available	Mar 17 2021
Publisher	Protein Data Bank (PDB)

DOI
10.2210/pdb7LYI/pdb

Access Dataset

https://www.wwpdb.org/pdb?id=pdb_00007lyi

Rational Design of Hybrid SARS-CoV-2 Main Protease Inhibitors Guided by the Superimposed Cocrystal Structures with the Peptidomimetic Inhibitors GC-376, Telaprevir, and Boceprevir
Xia, Z., Sacco, M., Hu, Y., Ma, C., Meng, X., Zhang, F., Szeto, T., Xiang, Y., Chen, Y. & Wang, J., Aug 13 2021, In: ACS Pharmacology and Translational Science. 4, 4, p. 1408-1421 14 p.
Research output: Contribution to journal › Article › peer-review

Open Access
79 Link opens in a new tab Scopus citations

Cite this

DataSetCite

Xia, Z. (Contributor), Sacco, M. (Contributor), Hu, Y. (Contributor), Ma, C. (Contributor), Meng, X. (Contributor), Zhang, F. (Contributor), Szeto, T. (Contributor), Xiang, Y. (Contributor), Chen, Y. (Contributor), Wang, J. (Contributor) (Mar 17 2021). Crystal structure of the SARS-CoV-2 (COVID-19) main protease in complex with inhibitor UAWJ9-36-3. Protein Data Bank (PDB). 10.2210/pdb7LYI/pdb

Crystal structure of the SARS-CoV-2 (COVID-19) main protease in complex with inhibitor UAWJ9-36-3

DOI

Access Dataset

Research output

Rational Design of Hybrid SARS-CoV-2 Main Protease Inhibitors Guided by the Superimposed Cocrystal Structures with the Peptidomimetic Inhibitors GC-376, Telaprevir, and Boceprevir

Cite this